Literature DB >> 15863853

Relapse of dermatomyositis after 10 years in remission following curative surgical treatment of lung cancer.

Hitoshi Mori1, Koji Habe, Arata Hakamada, Ken-ichi Isoda, Hitoshi Mizutani.   

Abstract

A 55-year-old woman with dermatomyositis and small cell lung cancer was successfully treated with surgery followed by combination chemotherapy in 1987. She had been in remission without further immunosuppressive therapy for 10 years. However, myositis with cutaneous manifestations specific for dermatomyositis relapsed when the patient was 69 years old. Intensive examinations revealed no neoplasm, and she responded to a moderate dose of systemic corticosteroids. This case suggests a long-lasting autoimmune abnormality in dermatomyositis and that a neoplasm is an important factor in eliciting an occult dermatomyositis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15863853     DOI: 10.1111/j.1346-8138.2005.tb00765.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  4 in total

Review 1.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

2.  Small cell lung cancer presenting as dermatomyositis: mistaken for single connective tissue disease.

Authors:  Guanqun Chao; Lizheng Fang; Chongrong Lu; Zhouwen Chen
Journal:  Rheumatol Int       Date:  2011-03-25       Impact factor: 2.631

3.  Dermatomyositis Associated with Lung Neuroendocrine Carcinoma.

Authors:  Reina Takashima; Kazufumi Takamatsu; Yutaka Shinkawa; Masato Yagita; Motonari Fukui; Masaaki Fujita
Journal:  Intern Med       Date:  2017-03-17       Impact factor: 1.271

4.  Ground-glass opacity heralding invasive lung adenocarcinoma with prodromal dermatomyositis: a case report.

Authors:  Andrew J Beel; David S Demos; Alfred Chung; Charles Liao; Natalie S Lui
Journal:  J Cardiothorac Surg       Date:  2018-02-07       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.